Institutional Investors Make Major Moves in Zevia Stock

Two prominent investment firms have significantly increased their stakes in Zevia PBC, with one institution growing its position by more than tenfold. These substantial acquisitions occur as the company’s shares have recently faced downward pressure in the market.

Acadian Asset Management dramatically expanded its investment by 950.8 percent, acquiring an additional 549,508 shares. This move brings the firm’s total holdings to approximately $1.31 million in value. Just two days earlier, Jacobs Levy Equity Management executed an even more substantial position increase of 2,701.2 percent.

Strong Fundamentals Support Optimism

The company’s improved operational performance appears to be driving this institutional confidence. Zevia’s second-quarter 2025 results exceeded expectations with several key achievements:

• Net revenue reached $44.5 million, representing 10.1% year-over-year growth
• The company achieved its first positive adjusted EBITDA as a public company at $0.2 million
• This marks a $4.6 million improvement compared to the same period last year

Strategic initiatives and enhanced productivity measures have facilitated this operational turnaround. Management has identified $15 million in planned savings by the end of 2025, with additional efficiencies targeted for 2026.

Analyst Perspectives Suggest Significant Potential

Market researchers maintain consistently optimistic views on Zevia, with the current consensus rating standing at “Moderate Buy” among four covering firms—two recommend purchasing shares while two suggest maintaining positions.

Should investors sell immediately? Or is it worth buying Zevia Pbc?

Price targets indicate substantial upside potential:

• Telsey Advisory Group and BMO Capital Markets: $6.00
• Morgan Stanley: $2.70
• Average price target: $4.61

This average target implies nearly 93 percent growth potential from the recent closing price of $2.38 per share.

Market Performance and Future Outlook

Despite the positive operational developments and institutional accumulation, share performance has recently diverged from fundamentals. The stock declined 0.83 percent to $2.38 in the latest session and has decreased 10.19 percent over the past ten trading days. Zevia’s current market valuation stands at approximately $174.83 million.

Attention now turns to the upcoming third-quarter earnings release scheduled for November 5, 2025. Analysts project an adjusted loss per share of $0.06 for the period. From a technical perspective, the $2.37 level currently provides important price support.

The substantial recent investments by institutional players represent a strong vote of confidence. Whether this institutional support can reverse the current downward trend will become clearer in the coming trading sessions.